Hardik Parikh
Stock Analyst at J.P. Morgan
(0.24)
# 4,555
Out of 5,004 analysts
29
Total ratings
24.1%
Success rate
-16.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Hardik Parikh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GPCR Structure Therapeutics | Reiterated: Buy | $100 | $35.93 | +178.32% | 7 | Aug 17, 2026 | |
| KLRA Kailera Therapeutics | Reiterated: Buy | $30 | $11.22 | +167.50% | 2 | Aug 12, 2026 | |
| VKTX Viking Therapeutics | Reiterated: Buy | $75 → $65 | $35.56 | +82.79% | 8 | Aug 11, 2026 | |
| PCRX Pacira BioSciences | Reiterated: Sell | $23 | $25.12 | -8.44% | 12 | Aug 10, 2026 |
Structure Therapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $100
Current: $35.93
Upside: +178.32%
Kailera Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $30
Current: $11.22
Upside: +167.50%
Viking Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: $75 → $65
Current: $35.56
Upside: +82.79%
Pacira BioSciences
Aug 10, 2026
Reiterated: Sell
Price Target: $23
Current: $25.12
Upside: -8.44%